The FDA declared the tirzepatide shortage over in October 2023, but reconsidered its decision following litigation by a compounding trade group. Image credit: GettyImages/ Scott
MSD already has a GLP-1RA/glucagon receptor co-agonist for the treatment of MASH. Image credit: Shutterstock / Tada Images. Merck & Co (MSD) has entered an
Online GLP-1RA products have become more prevalent amid popularity of Novo Nordisk’s and Eli Lilly’s approved treatments. Image credit: Shutterstock/ zimmytws. The US Food and
Ofev generated global sales of $3.8bn for the German drugmaker in 2023, up 12.8% from the year before. Image credit: Shutterstock / Michael Vi. Boehringer
There were protests in London earlier this year following the temporary ban against puberty blockers, which has now been made indefinite. Image credit: Getty /
There is currently no cure for genital herpes, though medication can control the infection. Image credit: Shutterstock / Richard Juilliart. A World Health Organization (WHO)
DMD leads to gradual decline in muscle function with children often needing to use a wheelchair by early adolescence. Image credit: Shutterstock/ New Africa. England’s
The BIOSECURE Act intends to prevent Chinese biotechs and manufacturers from accessing US funding and collaborating with US pharma companies. Image credit: Shutterstock/ fukomuffin. The
The biopharma said it is now reviewing feedback from the agency and plans to immediately meet with the FDA. Image credit: Shutterstock / The KonG.
Shares in Idorsia opened 17.5% higher following the news of its restructure. Image credit: Shutterstock / Taljat David. Idorsia is on the restructuring path again